Development of Chimera AMP–Endolysin with Wider Spectra Against Gram-Negative Bacteria Using High-Throughput Assay
Bacteriophage-derived endolysins are being developed as an alternative to antimicrobials. The development of endolysins against Gram-negative bacteria requires the discovery of effective endolysins against the target species and the capability to penetrate the outer membrane of bacteria by endolysin...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-01-01
|
| シリーズ: | Viruses |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1999-4915/17/2/200 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|